A comparison of the relative systemic availability of budesonide in asthmatic patients afterinhalation from the current US version of Pulmicort Turbuhaler and from two strengths of the new version of Pulmicort Turbuhaler.
Study identifier:SD-004-0601
ClinicalTrials.gov identifier:N/A
EudraCT identifier:N/A
CTIS identifier:N/A
Study Complete
Official Title
A comparison of the relative systemic availability of budesonide in asthmatic patients afterinhalation from the current US version of Pulmicort Turbuhaler and from two strengths of the new version of Pulmicort Turbuhaler.
Medical condition
asthma
Phase
Phase 1
Healthy volunteers
-
Study drug
-
Sex
-
Actual Enrollment
-
Study type
Interventional
Age
-
Date
Study Start Date: 01 Jan 2001
Primary Completion Date: -
Study Completion Date: -
Study design
Allocation: -
Endpoint Classification: -
Intervention Model: -
Masking: -
Primary Purpose: -
Verification:
Verified 01 Nov 2013 by AstraZeneca
Sponsors
AstraZeneca
Collaborators
-
Inclusion and exclusion criteria
Loading...
No locations available
| Arms | Assigned Interventions |
|---|
